mobile header
telelphone
Home > Doctors > Dr Goutam Santosh Panda
Dr Goutam Santosh Panda

Dr Goutam Santosh Panda american Oncology Hospitals

Dr Goutam Santosh Panda

Medical Oncology

Book an Appointment
Share Profile share

Dr. Goutam Santosh Panda is a highly skilled medical oncologist in Nagpur. He is currently working as a Consultant Medical Oncologist at the American Oncology Institute (AOI), Nagpur.

Dr. Goutam has expertise in treating a wide range of solid malignancies such as sarcomas, carcinomas, and lymphomas as well as hematological malignancies such as leukemia, lymphoma, and multiple myeloma. He is also well versed in neoadjuvant, adjuvant, concurrent, and palliative management of cancers.

Recognized as one of the top medical oncologists in Nagpur, Dr Goutam is trained in bone marrow transplant (hematopoietic stem cell transplant), and is highly skilled in targeted therapy and immunotherapy to treat different types of cancer.

An alumnus of the Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal, Dr Goutam pursued his MD in Radiation Oncology followed by D.M in Medical Oncology from the prestigious Tata Memorial Hospital, Mumbai.

Besides participating and attending numerous seminars and workshops, Dr Goutam has several publications in national and international journals to his credit. Dr Goutam actively participates in academic activities, data analysis, and research projects as well as clinical trials.

  • MBBS-Nil Ratan Sircar Medical College and Hospital, Kolkata, West Bengal (2011)
  • MD-Radiation Oncology, Tata Memorial Hospital, Mumbai (2016)
  • D.M-Medical Oncology, Tata Memorial Hospital, Mumbai (2021)
  • Dr Goutam has over ten years of experience in the field of medical oncology.

Publications

  • An Audit for Radiotherapy Planning and Treatment Errors From a Low-Middle-Income Country Centre. Clinical Oncology (Royal College of Radiologists). 2019;31(1):e67‐e74.
  • Adolescent–Adult Nonmetastatic Ewing Sarcoma—Experience from a Large Developing Country. Pediatric Blood and Cancer. 2021; 68:e29081.
  • Vascular Endothelial Growth Factor as a Potential Prognosticator in Ewing Sarcoma: A Tertiary Care Cancer Center Experience from India. 2022. Authorea Preprints.
  • COVID-19 Vaccine Uptake and Vaccine Hesitancy in Indian Patients with Cancer: A Questionnaire-Based Survey. 2021. Cancer Research, Statistics, and Treatment 4 (2): 211.
  • Outcomes of Ewing Sarcoma in Adults over 40 Years of Age from a Low-Middle Income Country, 2022. ecancer, 2022, March.
  • Long-Term Clinical Outcomes and Sequelae of Therapy in Early-Stage Orbital Mucosa-Associated Lymphoid Tissue Lymphoma. Clinical Lymphoma, Myeloma & Leukemia, 2021, December.
  • Small Cell Carcinoma of the Esophagus: Experience of an Indian Tertiary Cancer Center. ecancer. 2022. 16, 1393
  • Feasibility of Delivering High-Dose Methotrexate in Adolescent and Adult All Patients: A Retrospective Study. Indian Journal of Hematology & Blood Transfusion: An Official Journal of Indian Society of Hematology and Blood Transfusion.2021, 1-5.
  • Fibroblast Growth Factor Receptor (FGFR) Alterations in Head-and-Neck Cancer. Cancer Research, Statistics, and Treatment. 2021, 4 (4): 737.
  • Reg No: WBMC 68214
  • Hindi
  • English
  • Odia
  • Bengali
  • Marathi
  • Targeted Therapy
  • Immunotherapy
  • Chemotherapy for all types of solid and hematological malignancies.
  • Neoadjuvant, adjuvant, concurrent, and palliative therapy, including chemotherapy administration and supportive care.